Summary of Recent Business Developments in the Chemical and Pharmaceutical Industries
BASF and Evonik Industries
BASF has been in talks to acquire Evonik Industries, the second-largest chemical maker in Germany. Initially, Evonik rejected a €10.3 billion ($11.5 billion) offer from BASF due to a lack of premium compared to its stock price. Concerns regarding potential job losses from a merger have been raised by the German state of North Rhine-Westphalia, suggesting that further negotiations may be influenced by regional job security.
CJ CheilJedang and ADM Joint Venture
CJ CheilJedang and ADM are joining forces to create a joint venture focused on producing feed-grade amino acids in the U.S. and Brazil. This partnership comes amid increased regulation on imports from China, which both companies see as a strategic advantage.
Goodyear’s Exit from Chemicals
To fully exit the chemical business, Goodyear will close two plants in Texas and New York. The move follows the $650 million sale of its bulk chemical operations to Gemspring Capital in 2025, leaving these two plants, which produce various chemicals including antioxidants, outside that deal.
PTT and Siam Cement Merger
PTT Global Chemical and Siam Cement Group are set to merge their polyolefin businesses to bolster competitiveness amid a downturn in the petrochemical sector in Thailand. This consolidation addresses industry overcapacity.
Ancora’s Increased Bid for H.B. Fuller
Activist investor Ancora Holdings has increased its offer for H.B. Fuller’s building adhesives segment to between $1.2 billion and $1.4 billion, as it seeks to accelerate the company’s financial restructuring.
Solstice Advanced Materials Settlement
Solstice Advanced Materials has agreed to pay $80 million to settle pollution claims related to its uranium processing plant in Illinois. The lawsuit alleged that the company failed to prevent radioactive leaks, resulting in health issues within the local community.
Lynas Acquires Meteoric
Lynas Rare Earths plans to acquire Meteoric Resources to access a heavy rare earth-focused mine in Brazil. This acquisition aims to strengthen Lynas’s position in the rare earth market.
Other Notable Developments
- Arkema is investing $11 million to expand its battery research lab in France, anticipating significant growth in the battery materials market.
- Bayer is set to build a $2.2 billion pharmaceutical manufacturing site in Ohio, which will generate about 600 jobs and focus on essential medications.
- Invivyd announced successful Phase 3 trial results for an experimental COVID-19 antibody, with plans for accelerated FDA approval.
- Sanofi and Regeneron are expanding their collaboration on immunology drugs in a deal potentially worth $8 billion.
These activities illustrate significant shifts and consolidations in the chemical and pharmaceutical industries, underscoring strategic partnerships and the impacts of regulatory environments.
